Press-release for stocks related to therapeutics

tags : Therapeutics crawled time : 04:00

save search

Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
Published: 2024-04-12 (Crawled : 04:00) - globenewswire.com
NRIX | $14.125 4.01% 3.86% 690K

Health Technology

| -15.24% | O: -1.32% H: 2.19% C: 1.76%
million offering therapeutics

Alterity Therapeutics Receives a $3.9 million Research & Development Tax Incentive Refund
Published: 2024-03-26 (Crawled : 04:00) - alteritytherapeutics.com
ATHE | $2.14 0.47% 0.47% 32K

Health Technology

| 24.56% | O: 2.34% H: 5.11% C: 2.86%
million research therapeutics

Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2.06 billion between 2022 and 2027, Technavio
Published: 2024-03-26 (Crawled : 04:00) - prnewswire.com
ADCT | $4.97 6.2% 2.21% 400K

Health Technology

| 18.33% | O: 0.0% H: 8.1% C: 3.57%
therapeutics market

Kyverna Therapeutics Announces Pricing of Upsized Initial Public Offering
Published: 2024-02-08 (Crawled : 04:00) - prnewswire.com
MS | News | $93.76 1.81% 0.12% 6.4M

Finance

| 9.02% | O: -0.37% H: 0.64% C: -0.04%
offering therapeutics

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
Published: 2024-01-31 (Crawled : 04:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K

Professional, Scientific, and T...

| -35.81% | O: 1.16% H: 0.46% C: -5.29%
meeting therapeutics results

Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock
Published: 2024-01-05 (Crawled : 04:00) - globenewswire.com
MS | News | $93.76 1.81% 0.12% 6.4M

Finance

| 1.75% | O: 0.07% H: 1.87% C: 1.12%
DYN | $25.44 2.29% 2.24% 810K

Health Technology

| 31.2% | O: -8.25% H: 3.49% C: 0.96%
million offering therapeutics

Voyager Therapeutics Announces Pricing of Public Offering
Published: 2024-01-05 (Crawled : 04:00) - globenewswire.com
VYGR | News | $7.645 0.99% 0.98% 370K

Health Technology

| -29.43% | O: -17.62% H: 0.9% C: -0.9%
offering therapeutics

Sjogrens Syndrome Therapeutics Market report from 2022-2027 by Technavio - The market size to grow by USD 691.09 million during the forecast period
Published: 2023-12-15 (Crawled : 04:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630

Health Technology

| 7.13% | O: -1.81% H: 0.0% C: -1.79%
GSK | News | $41.24 1.6% 0.0% 2.3M

Health Technology

| 11.52% | O: -1.84% H: 0.3% C: -1.16%
report therapeutics market

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BCLI
Published: 2023-12-08 (Crawled : 04:00) - prnewswire.com
DMTK 4 | $0.6193 3.96% 3.81% 170K

Health Technology

| -57.24% | O: -2.76% H: 6.38% C: 4.26%
BCLI A | $0.531 -1.69% -1.71% 170K

Health Technology

| 138.74% | O: 0.0% H: 3.56% C: -9.77%
first deadline cell therapeutics

Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
Published: 2023-11-29 (Crawled : 04:00) - globenewswire.com
VERV | $6.88 -0.43% -0.44% 960K

Professional, Scientific, and T...

| -42.33% | O: -11.15% H: 13.21% C: 5.66%
LLY | News | $745.69 1.96% -0.16% 2M

Health Technology

| 26.0% | O: -0.06% H: 0.0% C: 0.0%
offering therapeutics

Karuna Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KarXT for the Treatment of Schizophrenia
Published: 2023-10-10 (Crawled : 04:00) - zailaboratory.com
KRTX | $329.83 0.0% 1.9M

Health Technology

| 90.66% | O: 0.93% H: 1.45% C: 0.77%
drug food treatment schizophrenia application therapeutics

Biologic therapeutics market size to increase by USD 286.12 billion from 2022 to 2027: Introduction of biosimilars to drive growth - Technavio
Published: 2023-05-10 (Crawled : 04:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630

Health Technology

| 6.2% | O: -1.66% H: 0.0% C: 0.0%
AZNCF | News | $138.73 -4.19% 3.7K

Health Technology

| -5.9% | O: 0.63% H: 0.64% C: 0.64%
NVSEF | News | $95.11 6.88% 490

Health Technology

| 10.24% | O: -1.24% H: 0.0% C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M

Health Technology

| -7.09% | O: -1.03% H: 0.26% C: 0.01%
GSK | News | $41.24 1.6% 0.0% 2.3M

Health Technology

| 13.14% | O: -0.03% H: 0.38% C: 0.25%
BAX | $41.02 1.54% 0.0% 2.6M

Health Technology

| -4.78% | O: 0.56% H: 1.99% C: 1.2%
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 15.47% | O: -0.21% H: 0.32% C: -0.07%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| -13.39% | O: -1.75% H: 0.0% C: 0.0%
BMRN | $92.06 2.87% 2.79% 1.3M

Health Technology

| -3.71% | O: 0.43% H: 0.0% C: -0.92%
AZN | News | $70.85 1.03% 1.02% 5.6M

Health Technology

| -5.63% | O: -0.53% H: 0.5% C: 0.25%
AMGN | News | $273.69 0.66% 0.65% 2.5M

Health Technology

| 16.68% | O: 0.2% H: 0.05% C: -0.33%
therapeutics growth market

Hospital Infection Therapeutics Market to grow at a CAGR of 4.98% from 2022 to 2027, antibiotics to be a major segment for the growth of the market - Technavio
Published: 2023-03-16 (Crawled : 04:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630

Health Technology

| 15.79% | O: -0.23% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -0.38% | O: -0.07% H: 1.96% C: 0.56%
AZNCF | News | $138.73 -4.19% 3.7K

Health Technology

| 9.75% | O: 0.77% H: 1.14% C: 0.96%
NVSEF | News | $95.11 6.88% 490

Health Technology

| 42.66% | O: 1.16% H: 0.73% C: 0.73%
VTRS | News A | $11.36 0.98% 0.97% 4.7M

Health Technology

| 19.58% | O: -1.58% H: 1.93% C: 1.6%
NVS | News | $97.28 2.27% 0.31% 3.7M

Health Technology

| 18.49% | O: 0.18% H: 0.77% C: 0.64%
GSK | News | $41.24 1.6% 0.0% 2.3M

Health Technology

| 22.81% | O: -0.89% H: 1.64% C: 1.62%
ABBV | News | $169.54 0.98% -0.91% 4.1M

Health Technology

| 10.05% | O: -0.56% H: 1.78% C: 1.37%
ABT | News | $107.59 0.49% -0.09% 3.8M

Health Technology

| 10.01% | O: -0.76% H: 2.29% C: 2.03%
SNY | News | $47.69 1.15% 1.13% 1.7M

Health Technology

| 1.23% | O: 1.01% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M

Health Technology

| 9.71% | O: 0.36% H: 1.87% C: 1.81%
infection antibiotics therapeutics growth market

Alterity Therapeutics Enrolls First Patient in Italy in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy
Published: 2023-03-08 (Crawled : 04:00) - alteritytherapeutics.com
ATHE | $2.14 0.47% 0.47% 32K

Health Technology

| -34.46% | O: 2.49% H: 0.57% C: -0.92%
ath434 system trial therapeutics phase 2

Travere Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Published: 2023-03-01 (Crawled : 04:00) - globenewswire.com
TVTX | $5.745 -1.8% -1.83% 1.2M

Health Technology

| -74.1% | O: -1.17% H: 3.56% C: -0.73%
offering therapeutics

Global Microbiome Therapeutics Market Analysis Report 2023: A $1.46 Billion Market by 2027 Featuring Major Players - Assembly Bio, Finch Therapeutics, Second Genome, Evelo Bio, Ysopia Bio
Published: 2023-02-10 (Crawled : 04:00) - prnewswire.com
TOVX | News | $0.3769 -8.3% -1.83% 1.2M

Manufacturing

| -64.89% | O: 2.57% H: 0.0% C: -6.31%
FNCH | $2.79 20.78% 17.2% 510K

Professional, Scientific, and T...

| -80.98% | O: -3.01% H: 4.34% C: 3.31%
global report therapeutics market

Acrivon Therapeutics Announces Pricing of Initial Public Offering
Published: 2022-11-15 (Crawled : 04:00) - globenewswire.com
ACRV | $9.82 3.26% 3.16% 320K